Corticosteroids in the palliative therapy of preterminal and terminal cancer patients: Evidence or empericism?;Kortikosteroider i palliation af præterminale og terminale cancerpatienter: Evidens eller empiri?

Ugeskrift for Laeger

Volumn 165, Issue 41, 2003, Pages 3913-3917

  Henriksen, Hans ^a   Gamborg, Helle ^b   Leikersfeldt, Gerd ^b  

^a Hospice og Hjemmehospice   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; FLUOXYMESTERONE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; ANTIEMETIC AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; GLUCOCORTICOID;

CANCER; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG EFFECT; DYSPEPSIA; EMPIRICISM; EVIDENCE BASED MEDICINE; HUMAN; PRACTICE GUIDELINE; REVIEW; TERMINAL CARE; TREATMENT OUTCOME; ULCER; PALLIATIVE THERAPY;

ANTI-INFLAMMATORY AGENTS; ANTIEMETICS; ANTINEOPLASTIC AGENTS, HORMONAL; CLINICAL TRIALS; DEXAMETHASONE; EVIDENCE-BASED MEDICINE; GLUCOCORTICOIDS; HUMANS; METHYLPREDNISOLONE; PALLIATIVE CARE; PREDNISOLONE; TERMINAL CARE;

EID: 0142151016     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Bruera E, Roca E, Cedara S et al. Action of oral methylprednisolone in terminal cancer patients: a prospective randomised double-blind study. Cancer Treat Rep 1985;69:751-4.
2. Cuna G, Pellegrini A, Piazzi M. Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled multicenter study. Eur J Cancer Clin Oncol 1989;25:1817-21.
3. Popiela T, Lucchi R, Giongo F. Methylprednisolone as palliative therapy for female terminal cancer patients. Eur J Cancer Clin Oncol 1989;25:1823-9.
4. Moertel CG, Schutt AJ, Reitemeer RJ et al. Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 1974;33:1607-9.
5. Twycross R, Guppy D. Prednisolone in terminal breast and bronchogenic cancer. Practitioner 1985;229:57-9.
6. Willox JC, Corr J, Shaw J et al. Prednisolone as an appetite stimulant in patiens with cancer. BMJ 1984;288:27.
7. Lai Y, Fang F, Yeh C. Management of anorexic patients in radiotherapy: a prospective randomized comparison of megestrol and prednisolone. J Pain Sympt Manage 1994;9:265-8.
8. Loprinzi CL, Kugler JW, Sloan JA et al. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 1999;17:3299-306.
9. Hanks GW, Trueman T, Twycross RG. Corticosteroids in terminal cancer - a prospective analysis of current practice. Postgraduate Med J 1983;59: 702-6.
10. Mercadante S, Fulfaro F, Casuccia A. The use of corticosteroids in home palliative care. Support Care Cancer 2001;9:386-9.
11. Hardy JR, Rees E, Ling J et al. A prospective survey of the use of dexamethasone on a palliative care unit. Pall Med 2001;15:3-8.
12. Tannock I, Gospodarowicz M, Meakin W et al. Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 1989;7:590-7.
13. Ettinger AB, Portenoy RK. The use of corticosteroids in the treatment of symptoms associated with cancer. J Pain Sympt Manage 1988;3:99-103.
14. Hillier R. Control of pain in terminal cancer. Br Med Bull 1990;46:279-91.
15. Bruera E, Portenoy RK, ed. Topics in palliative care. Oxford University Press, New York 1998: vol. 2:48-9.
16. Sykes J, Johnson R, Hanks GW. Difficult pain problems. BMJ 1997;315: 867-9.
17. O'Neill B, Fallon M. Principles of palliative care and pain control. BMJ 1997;315:801-4.
18. Doyle D, Hanks G, McDonald N, eds. Oxford textbook of palliative medicine. Oxford: Oxford University Press 1998:366-8,595-6.
19. Woolbridge JE, Anderson CM, Perry MC. Corticosteroids in advanced cancer. Oncology 2001;15:225-34.
20. Beck-Friis B, Strang P, eds. Palliativ medicin. Stockholm: Liber, 1995:278-83,299.
21. Bruera E. Anorexia, cachexia and nutrition. BMJ 1997;315:1219-22.
22. Davis MP, Dickerson D. Cachexia and anorexia: cancer's covert killer. Support Care Cancer 2000;8:180-7.
23. Vigano A, Watanabe S, Bruera E. Anorexia and cachexia in advanced cancer patients. Cancer Surveys 1994;21:99-115.
24. Baines MJ. Nausea, vomiting and intestinal obstruction. BMJ 1997;315: 1148-50.
25. Bruera E, Seifert L, Watanabe S et al. Chronic nausea in advanced cancer patients. J Pain Sympt Manage 1996;11:147-53.
26. Davis CL. Breathlessness, cough and other respiratory problems. BMJ 1997; 315:931-4.
27. Feuer DJ, Broadley KE. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynecological and gastrointestinal cancer (Cochrane Review). I: The Cochrane Library, Issue 2, 2001. Oxford: Update software.
28. Ripamonti C, Twycross R, Baines M et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 2001;9:223-33.
29. Oneschuk D, Bruera E. Palliative management of brain metastases. Support Care Cancer 1998;6:365-72.
30. Jarlbæk L, Gram LF, Arnberg A. Bivirkninger ved kortvarig steroidbehandling. Ugeskr Læger 2000;162:528-9.
31. Stiefel FC, Breitbart WS, Holland JC. Corticosteroids in cancer: neuropsychiatric complications. Cancer Invest 1989;7:479-91.
32. Chrousos GA, Kattah JC, Beck RW et al. Side effects of glucocorticoid treatment. JAMA 1993;269:2110-2.
33. Weissman DE, Dufer D, Vogel V et al. Corticosteroid toxicity in neuro-oncology patients. J Neurooncol 1987;5:125-8.
34. Conn HO, Blitzer BL. Nonassociation of adreno corticosteroid therapy and peptic ulcer. N Engl J Med 1976;294:473-9.
35. Messer J, Reitman D, Sacks HS et al. Association of adreno-corticosteroid therapy and peptic ulcer disease. N Engl J Med 1983;309:21-4.
36. Piper JM, Ray WA, Daugherty JR et al. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Int Med 1991; 114:735-40.
37. Carson JL, Strom BL, Schinnar R, Sim E. The low risk of upper gastrointestinal bleeding in patients dispensed corticosteroids. Am J Med 1991;91:223-8.
38. Guslandi M, Tittobello A. Steroid ulcers: a myth revisited. BMJ 1992;304: 655-6.
39. Needham PR, Daley AG, Lennard RF. Steroids in advanced cancer: survey of current practice. BMJ 1992;305:999.
40. Twycross R. Corticosteroids in advanced cancer. BMJ 1992;305:969.